ARQ-323

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameARQ-323
Drug Alias NameAQ-323
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV protease inhibitors
TargetsHIV protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArqule Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A